KRAS mutation, a common driver of lung adenocarcinoma, is associated with KEAP1 loss-of-function mutations in approximately 20% of KRAS mutant NSCLC cases, forming a KRAS-KEAP1 co-mutation (KK) type. The gene discussed is KRAS; the disease is non-small cell lung carcinoma.